Department of Orthopaedics, University of Heidelberg, 69118 Heidelberg, Germany.
J Surg Oncol. 2010 Feb 1;101(2):166-9. doi: 10.1002/jso.21441.
Limb salvage and reconstruction with tumor endoprostheses is considered as therapeutic standard in the treatment of bone defects at the knee. Few studies report long-term results so far.
Seventy-seven patients who had a cementless or cemented MUTARS endoprosthesis implanted were followed-up for a mean period of 46 months (3-128 months). The defects were due to primary tumor lesions in 69 cases or metastases in 8 cases. The distal femur (n = 49) or the proximal tibia (n = 28) was reconstructed predominantly with cementless implants (femur: 69%, tibia: 92%). The resection of the tumor was intraarticular in 46 and extraarticular in 31 patients.
After 10 years probability of limb salvage was 92% with a recurrence rate of 3%. Complications were frequent with a revision rate of 58% and lead to a cumulative probability of survival of the initially implanted prosthesis of 57% after 5 years. Locking mechanism failure (n = 15) and aseptic loosening (n = 13) were the most frequent failure modes.
Regardless of achieving a low recurrence rate and satisfactory functional results, we found a high complication rate after implantation of a megaprosthesis. This was particularly evident for extraarticular resections and cemented fixation, which should be avoided when possible.
在膝关节骨缺损的治疗中,使用肿瘤假体进行保肢和重建被认为是一种治疗标准。到目前为止,很少有研究报告长期结果。
对 77 例植入非骨水泥或骨水泥 MUTARS 假体的患者进行了平均 46 个月(3-128 个月)的随访。这些缺损是由 69 例原发性肿瘤病变或 8 例转移引起的。股骨(n=49)或胫骨(n=28)主要采用非骨水泥植入物重建(股骨:69%,胫骨:92%)。46 例患者肿瘤切除为关节内,31 例为关节外。
10 年后,保肢率为 92%,复发率为 3%。并发症频繁,翻修率为 58%,导致最初植入假体的 5 年后累计生存率为 57%。锁定机制失效(n=15)和无菌性松动(n=13)是最常见的失效模式。
尽管实现了低复发率和令人满意的功能结果,但我们发现植入大型假体后并发症发生率较高。对于关节外切除和骨水泥固定,这种情况更为明显,应尽可能避免。